Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Urinary Tract Infection: full-pipeline trial registry

2 of 12 indexed Urinary Tract Infection trials are currently recruiting.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 2 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Urinary Tract Infection: 12 US clinical trials tracked, 2 recruiting.

Urinary Tract Infection is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is University of Washington, running 2 of these trials.

Enrollment posture brief

Registry condition urinary-tract-infection

OPEN 2 | RECR 17% | LATE 3 | EARLY 4 | RANK #1429 | SPON 2

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Urinary Tract Infection (thi…17%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Urinary Tract Infection

Urinary Tract Infection lists 2 open slots (17% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Urinary Tract Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Urinary Tract Infection is recruiting below its size-band peers.

    2 of 12 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Urinary Tract Infection research.

    University of Washington accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Typical Urinary Tract Infection enrolment sits around 300 participants.

    Median target enrolment is 300 among the 12 trials that report a genuine target (sentinel values excluded). 1 of those (8.3%) plan for fewer than 100 participants.

  4. Urinary Tract Infection research is mostly interventional.

    11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 23Phase 32Phase 41

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 300 participants

The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.

Ohio State University

NCT07239219

RECRUITING NA 23 participants

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

Icahn School of Medicine at Mount Sinai

NCT06689176

COMPLETED 3,000 participants

ParentLink: Better and Safer Emergency Care for Children

Boston Children's Hospital

NCT00457600

COMPLETED Phase 3 1,690 participants

A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Spero Therapeutics

NCT06059846

COMPLETED Phase 3 546 participants

Corticosteroids for Children With Febrile Urinary Tract Infections

Nader Shaikh

NCT01391793

COMPLETED NA 425 participants

Healthy.io Method Comparison & User Performance Study

Healthy.io

NCT02785445

COMPLETED Phase 2 338 participants

Short Course Nitrofurantoin for Acute Cystitis

University of Washington

NCT00391651

COMPLETED NA 300 participants

Cefpodoxime vs Ciprofloxacin for Acute Cystitis

University of Washington

NCT00194532

COMPLETED Phase 1 208 participants

Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections

Cook County Health

NCT00130221

COMPLETED Phase 2 200 participants

Preventing Urinary Tract Infection Post-Surgery

Betsy Foxman

NCT01346774

COMPLETED Phase 2 200 participants

A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures

Children's Mercy Hospital Kansas City

NCT00142064

COMPLETED Phase 4 180 participants

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

Bayer

NCT00669994

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Urinary Tract Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ciprofloxacin Drug
2 trials
TMP/SMX DS twice daily x 3 days Drug
1 trials
Nitrofurantoin 100mg twice daily x 5 days Drug
1 trials
ACON U500 Mission® U500 Urine Analyzer Device
1 trials
Dip.io Home Based Dipstick Analyzer Device
1 trials
Dummy Tablets Drug
1 trials
Dummy Infusion Drug
1 trials
Imipenem-cilastatin Drug
1 trials

US sites by state

Facility locations filed on Urinary Tract Infection trials. A trial with sites in several states counts in each.

New York 3 trials
Florida 3 trials
Washington 2 trials
Ohio 2 trials
Michigan 2 trials
Massachusetts 2 trials
Wisconsin 1 trials
Utah 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Urinary Tract Infection page

12 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Urinary Tract Infection condition card totals 12 registered trials; most-linked intervention Ciprofloxacin; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.